A super short ruling from the U.S. Patent Trial and Appeal Board found no “interference,” in patents awarded to Harvard and Broad Institute scientist Feng Zhang, related to the use of a novel ...

Some of Steven Pipe’s hemophilia patients consider themselves cured. In a trial Pipe led from 2018 to 2021, they received a one-time gene therapy meant to override a DNA mutation that causes ...